Xiang Mei

Title: **Innovative Advances by Inventor Xiang Mei**

Introduction

Xiang Mei, an accomplished inventor based in Chongqing, China, has made significant contributions to the field of biomedicine. With two patents to his name, he has focused on developing innovative solutions for medical conditions such as hyperuricemia and chronic gout. His groundbreaking work emphasizes the importance of addressing these health issues through advanced biotechnological methods.

Latest Patents

Among his latest patents is the invention of a PEGylated analogue protein of canine urate oxidase, alongside its preparation method and applications. This PEGylated analogue serves as a potential treatment for hyperuricemia and chronic gout by offering an effective pharmaceutical composition derived from canine urate oxidase. The invention also includes a chimeric protein that combines amino acid sequences from both canine and human urate oxidases, enhancing its utility in medical applications.

In addition, Xiang Mei has developed a humanized recombinant uricase and its mutants. This humanized recombinant protein is crafted to minimize immunogenicity in humans, making it a promising candidate for the treatment of hyperuricemia and gout. By fusing amino acid sequences of non-human mammal uricase with those of human uricase, this invention showcases Mei’s commitment to improving patient outcomes in chronic conditions.

Career Highlights

Throughout his career, Xiang Mei has made notable contributions to the biomedical field. His work at Chongqing Fagen Biomedical Inc. has been pivotal, allowing him to apply his research into practical, real-world applications. His innovative spirit and dedication to biomedicine have helped shape new therapies for challenging health conditions.

Collaborations

Xiang Mei has collaborated with several notable individuals in the field, including Chun Zhang and Kai Fan. These partnerships have enhanced his research efforts and contributed to the successful development of his patented technologies, fostering an environment of innovation and scientific advancement.

Conclusion

Xiang Mei's contributions as an inventor in Chongqing reflect a promising future for biomedical innovation. His patents on novel therapeutic proteins highlight significant advances in the treatment of hyperuricemia and gout, targeting critical health challenges. With continued collaboration and research, Xiang Mei is poised to make even greater impacts in the field of medicine.